Clinical Trials Logo

Clinical Trial Summary

The study is being conducted to evaluate the tolerance, and safety of HRS-8080 tablets monotherapy and combined with other anti-cancer therapy for metastatic or local advanced breast cancer in adults. To explore the reasonable dosage of HRS-8080 tablets for metastatic or local advanced breast cancer.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05189717
Study type Interventional
Source Shandong Suncadia Medicine Co., Ltd.
Contact Wenjie Xin
Phone +86 17721286316
Email [email protected]
Status Not yet recruiting
Phase Phase 1
Start date January 31, 2022
Completion date July 31, 2025